Telomerase activity and p53-dependent apoptosis in ovarian cancer cells

被引:10
作者
Akeshima, R [1 ]
Kigawa, J [1 ]
Takahashi, M [1 ]
Oishi, T [1 ]
Kanamori, Y [1 ]
Itamochi, H [1 ]
Shimada, M [1 ]
Kamazawa, S [1 ]
Sato, S [1 ]
Terakawa, N [1 ]
机构
[1] Tottori Univ, Sch Med, Dept Obstet & Gynecol, Yonago, Tottori 6838504, Japan
基金
美国国家卫生研究院;
关键词
telomerase; p53; apoptosis; ovarian cancer cells;
D O I
10.1054/bjoc.2001.1812
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We conducted the present study to determine the relationship between p53-dependent apoptosis and telomerase activity in ovarian cancer cells. A human ovarian adenocarcinoma cell line, SK-OV-5 that had homozygous deletion of the p53 gene was used in this study. Wild-type p53 genes were transducted to SK-OV-3 cells with a recombinant adenovirus that contained a wild-type p53 gene (AxCAp53). IC50 to cisplatin (CDDP) was 12.9 muM for SK-OV-3 cells and 9.2 muM for p53 gene-transducted SK-OV-3 cells. The apoptotic index for cells with p53 gene transduction was significantly higher than cells without transduction. Additionally, p53 gene transduction significantly enhanced CDDP-induced apoptosis. Bax protein in SK-OV-3 cells did not differ before and after exposure to CDDP. In SK-OV-3 cells with transduction of the p53 gene, the expression of p53 and Bax proteins increased after exposure to CDDP. Expression of Bcl-xL decreased after exposure to CDDP in SK-OV-3 cells with and without transduction. The telomerase activity in SK-OV-3 cells with the p53 gene was significantly lower compared with the cells without the p53 gene. CDDP exposure did not affect telomerase activity and human telomerase reverse transcriptase (hTERT) expression in both cell lines. We suggest that the p53 gene may relate to telomerase activity, but that p53-dependent apoptosis does not affect the activity. (C) 2001 Cancer Research Campaign.
引用
收藏
页码:1551 / 1555
页数:5
相关论文
共 26 条
  • [1] Cytostatic concentrations of anticancer agents do not affect telomerase activity of leukaemic cells in vitro
    Akiyama, M
    Horiguchi-Yamada, J
    Saito, S
    Hoshi, Y
    Yamada, O
    Mizoguchi, H
    Yamada, H
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 (02) : 309 - 315
  • [2] TELOMERASES
    BLACKBURN, EH
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1992, 61 : 113 - 129
  • [3] BCL-X, A BCL-2-RELATED GENE THAT FUNCTIONS AS A DOMINANT REGULATOR OF APOPTOTIC CELL-DEATH
    BOISE, LH
    GONZALEZGARCIA, M
    POSTEMA, CE
    DING, LY
    LINDSTEN, T
    TURKA, LA
    MAO, XH
    NUNEZ, G
    THOMPSON, CB
    [J]. CELL, 1993, 74 (04) : 597 - 608
  • [4] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [5] Inhibition of telomerase activity by cisplatin in human testicular cancer cells
    Burger, AM
    Double, JA
    Newell, DR
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 (04) : 638 - 644
  • [6] p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis
    Chin, L
    Artandi, SE
    Shen, Q
    Tam, A
    Lee, SL
    Gottlieb, GJ
    Greider, CW
    DePinho, RA
    [J]. CELL, 1999, 97 (04) : 527 - 538
  • [7] FRITSCHE M, 1993, ONCOGENE, V8, P307
  • [8] TELOMERASE, CELL IMMORTALITY, AND CANCER
    HARLEY, CB
    KIM, NW
    PROWSE, KR
    WEINRICH, SL
    HIRSCH, KS
    WEST, MD
    BACCHETTI, S
    HIRTE, HW
    COUNTER, CM
    GREIDER, CW
    PIATYSZEK, MA
    WRIGHT, WE
    SHAY, JW
    [J]. COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 1994, 59 : 307 - 315
  • [9] Real time quantitative PCR
    Heid, CA
    Stevens, J
    Livak, KJ
    Williams, PM
    [J]. GENOME RESEARCH, 1996, 6 (10): : 986 - 994
  • [10] EXPRESSION AND PROGNOSTIC-SIGNIFICANCE OF BCL-2 IN OVARIAN-TUMORS
    HENRIKSEN, R
    WILANDER, E
    OBERG, K
    [J]. BRITISH JOURNAL OF CANCER, 1995, 72 (05) : 1324 - 1329